Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03493126 · ClinicalTrials.gov registry record · Phase 4
Vaginal Estrogen on Postpartum Atrophy, Perineal Pain, and Sexual Function
A Phase 4 study, sponsored by Ohio State University.
- Completed
- Registry status
- Phase 4
- Development phase
- 59
- Enrollment target
NCT03493126 is a Phase 4 study that has completed, run by Ohio State University. The registered enrollment target is 59 participants.
The verdict
NCT03493126, a Phase 4 study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 59 participants
- Enrollment target
Study Summary
Pilot randomized, placebo-controlled trial of nulliparous postpartum women with a perineal laceration following a term vaginal delivery comparing vulvovaginal atrophy symptoms between women using vaginal estrogen in the postpartum period with those using placebo.
Interventions
- OTHER Placebo
- DRUG Estradiol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2018-10-15 |
| Est. Completion | 2020-09-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03493126
The ClinicalTrials.gov registry entry for NCT03493126 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03493126 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03493126 about?
NCT03493126 is a clinical study titled "Vaginal Estrogen on Postpartum Atrophy, Perineal Pain, and Sexual Function". Pilot randomized, placebo-controlled trial of nulliparous postpartum women with a perineal laceration following a term vaginal delivery comparing vulvovaginal atrophy symptoms between women using vaginal estrogen in the postpartum period with those using placebo.
What is the current status of trial NCT03493126?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 59 participants. The study started on 2018-10-15. Estimated completion is 2020-09-01.
What interventions are being tested in trial NCT03493126?
The interventions under investigation include: Placebo (OTHER), Estradiol (DRUG).
Who is sponsoring clinical trial NCT03493126?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.